Print this page    •   Back to Web version of article

Medical News
Methamphetamine and Sildenafil (Viagra) Use Are Linked to Unprotected Receptive and Insertive Anal Sex, Respectively, in a Sample of Men Who Have Sex With Men

June 7, 2006

In the current study, researchers investigated the association of methamphetamine, sildenafil, and other substance use with unprotected receptive and insertive anal sex among men who have sex with men (MSM) through an encounter-specific analysis. With data from a cross-sectional, community-based survey of MSM in San Francisco regarding behavior during their most recent anal sex encounter, researchers used multivariate regression to analyze independent associations of specific substance use and demographic variables with unprotected anal sex behaviors.

The sample (n=388) was diverse in terms of race/ethnicity, age, income, education, HIV status, and homosexual/bisexual identification. Of the sample, 53 percent reported unprotected anal sex, including insertive (29 percent) and receptive (37 percent) during their most recent anal sex encounter. Twelve percent reported unprotected insertive anal sex with an HIV discordant partner or partner of unknown serostatus; 17 percent reported unprotected receptive anal sex with an HIV discordant partner or partner of unknown serostatus. Fifteen percent of the sample used methamphetamine before or during the encounter; 6 percent used sildenafil; and 2 percent used both drugs.

In multivariate analysis controlling for demographic factors and other substance use, the investigators found methamphetamine use was associated with unprotected receptive (odds ratio (OR), 2.03; 95 percent confidence interval (CI), 1.09 to 3.76) and sildenafil use was associated with unprotected insertive (OR, 6.51; CI, 2.46 to 17.24) anal sex. Effects were stronger with HIV discordant or unknown sex partners specifically.

"Encounter-specific associations of methamphetamine and sildenafil use with unprotected receptive and insertive anal sex, respectively, indicate the importance of assessment specificity and tailoring risk reduction efforts to address certain drugs and sexual behavioral roles among MSM," the authors concluded.

Back to other news for June 7, 2006

Excerpted from:
Sexually Transmitted Infections
04.06; Vol. 82; No. 2: P. 131-134; G. Mansergh; R.L. Shouse; G. Marks; R. Guzman; M. Rader; S. Buchbinder; G.N. Colfax

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.